Advancements in PARP1 Targeted Nuclear Imaging and Theranostic Probes.

Ramya Ambur Sankaranarayanan; Susanne Kossatz; Wolfgang Weber; Mohsen Beheshti; Agnieszka Morgenroth; Felix M Mottaghy

doi:10.3390/jcm9072130

Advancements in PARP1 Targeted Nuclear Imaging and Theranostic Probes.

Ramya Ambur Sankaranarayanan, Susanne Kossatz, Wolfgang Weber, Mohsen Beheshti (Co-author), Agnieszka Morgenroth, Felix M Mottaghy

Department of Nuclear Medicine and Endocrinology

Research output: Contribution to journal › Review article › peer-review

26 Citations (Web of Science)

Original language	English
Journal	Journal of Clinical Medicine
Volume	9
Issue number	7
DOIs	https://doi.org/10.3390/jcm9072130
Publication status	Published - 2020

Keywords

DNA-DAMAGE
IN-VITRO
PET
EXPRESSION
INHIBITOR
GLIOBLASTOMA
RADIOTRACER
STRATEGY
OLAPARIB
DELIVERY

Access to Document

10.3390/jcm9072130

Cite this

@article{e03ae354c9e34036b4e2b331cefedd55,

title = "Advancements in PARP1 Targeted Nuclear Imaging and Theranostic Probes.",

keywords = "DNA-DAMAGE, IN-VITRO, PET, EXPRESSION, INHIBITOR, GLIOBLASTOMA, RADIOTRACER, STRATEGY, OLAPARIB, DELIVERY",

author = "{Ambur Sankaranarayanan}, Ramya and Susanne Kossatz and Wolfgang Weber and Mohsen Beheshti and Agnieszka Morgenroth and Mottaghy, {Felix M}",

note = "Beheshti: Paracelsus Med Univ, Dept Nucl Med *** Endocrinol, A-5020 Salzburg, Austria;",

year = "2020",

doi = "10.3390/jcm9072130",

language = "English",

volume = "9",

journal = "Journal of Clinical Medicine",

issn = "2077-0383",

publisher = "MDPI",

number = "7",

}

TY - JOUR

T1 - Advancements in PARP1 Targeted Nuclear Imaging and Theranostic Probes.

AU - Ambur Sankaranarayanan, Ramya

AU - Kossatz, Susanne

AU - Weber, Wolfgang

AU - Beheshti, Mohsen

AU - Morgenroth, Agnieszka

AU - Mottaghy, Felix M

N1 - Beheshti: Paracelsus Med Univ, Dept Nucl Med *** Endocrinol, A-5020 Salzburg, Austria;

PY - 2020

Y1 - 2020

KW - DNA-DAMAGE

KW - IN-VITRO

KW - PET

KW - EXPRESSION

KW - INHIBITOR

KW - GLIOBLASTOMA

KW - RADIOTRACER

KW - STRATEGY

KW - OLAPARIB

KW - DELIVERY

U2 - 10.3390/jcm9072130

DO - 10.3390/jcm9072130

M3 - Review article

C2 - 32640708

SN - 2077-0383

VL - 9

JO - Journal of Clinical Medicine

JF - Journal of Clinical Medicine

IS - 7

ER -